Early research (Phase 1)Active Not RecruitingNCT02950766What this trial is testingNeoVax Plus Ipilimumab in Renal Cell CarcinomaWho this might be right forKidney Cancer Patrick Ott, MD, PhD 19
Early research (Phase 1)Study completedNCT00625456What this trial is testingSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsWho this might be right forMelanomaLung CancerRenal Cell Carcinoma+1 more Jennerex Biotherapeutics 23
Testing effectiveness (Phase 2)Study completedNCT03548467What this trial is testingEvaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic CancerWho this might be right forLocally Advanced or Metastatic Solid Tumours Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Study completedNCT00012337What this trial is testingZD 1839 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02489695What this trial is testingAxitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell CarcinomaWho this might be right forPapillary Renal Cell Carcinoma Centre Leon Berard 44
Early research (Phase 1)Active Not RecruitingNCT06132945What this trial is testingCabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the BrainWho this might be right forMetastatic Renal Cell CarcinomaBrain Metastases Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06574412What this trial is testingCardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.Who this might be right forResectable Clear Cell Carcinoma of the Kidney The First Hospital of Jilin University 30
Not applicableUnknownNCT02734329What this trial is testingZero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 StageWho this might be right forKidney Neoplasms RenJi Hospital 600
Not applicableStudy completedNCT01173445What this trial is testingCirculating Tumors Cells and Circulating Endothelial Cells in Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma University of Kansas 19
Not applicableStudy completedNCT01367457What this trial is testingINHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With TemsirolimusWho this might be right forCarcinoma, Renal CellLymphoma, Mantle-Cell Pfizer 243
Very early researchStudy completedNCT03473730What this trial is testingDaratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerWho this might be right forBladder Urothelial CarcinomaClear Cell Renal Cell CarcinomaMalignant Urinary System Neoplasm+2 more M.D. Anderson Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT00720941What this trial is testingPazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 1,110
Early research (Phase 1)Study completedNCT00001683What this trial is testingA Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerWho this might be right forLymphomaMelanomaNeoplasm Metastasis+1 more National Cancer Institute (NCI) 35
Not applicableStudy completedNCT01339962What this trial is testingRetrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.Who this might be right forRenal Cell Carcinoma Pfizer 1,073
Not applicableStudy completedNCT04222374What this trial is testingUro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)Who this might be right forKidney Cancer University Hospital, Bordeaux 200
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106
Large-scale testing (Phase 3)Study completedNCT00291369What this trial is testingCytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate PrognosisWho this might be right forMetastatic Renal Cell Carcinoma Centre Leon Berard 456
Testing effectiveness (Phase 2)UnknownNCT00024388What this trial is testingChemotherapy in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Theradex
Not applicableUnknownNCT05243173What this trial is testingBiomarkers of Response to Systemic Treatments in FH-deficient RCCWho this might be right forMetabolomicsRenal Cell CarcinomaFH-Deficient RCC+1 more RenJi Hospital 100
Not applicableLooking for participantsNCT07301827What this trial is testingStudy on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 66